Target intelligence / Profile preview

ATP-binding cassette subfamily C member 2 (ABCC2) and ATP-binding cassette subfamily B member 4 (ABCB4) (ABCC2/ABCB4/ABCB11)

Target
ABCC2/ABCB4/ABCB11
Molecular classification
Transporter, ATP-binding cassette (ABC) transporter family
01

Overview

Hepatobiliary ATP-binding cassette (ABC) transporters, primarily ABCC2 (MRP2), ABCB4 (MDR3), and the related ABCB11 (BSEP), are essential proteins located on the canalicular membrane of hepatocytes that drive the secretion of bile components. ABCC2 facilitates the transport of conjugated bilirubin and various organic anions, while ABCB4 acts as a phospholipid flippase, providing phosphatidylcholine to protect the biliary epithelium from the detergent effects of bile salts, which are themselves primarily transported by ABCB11 [3, 15, 17]. Dysfunction of these transporters, whether through genetic mutations or drug-induced inhibition, leads to a variety of cholestatic liver diseases, including progressive familial intrahepatic cholestasis (PFIC), Dubin-Johnson syndrome, and intrahepatic cholestasis of pregnancy [5, 11, 14]. These transporters are also significant in pharmacology as they mediate the efflux of numerous drugs and their metabolites, contributing to multidrug resistance in cancer and serving as a major site for drug-induced liver injury (DILI) [1, 6, 23]. Therapeutic strategies often involve the use of nuclear receptor agonists, such as farnesoid X receptor (FXR) or pregnane X receptor (PXR) ligands, to induce the expression and trafficking of these transporters to restore bile flow and detoxification capacity [10, 15, 18].

Other names
Multidrug resistance-associated protein 2 (MRP2)Multidrug resistance protein 3 (MDR3)Bile salt export pump (BSEP)Canalicular multispecific organic anion transporter (cMOAT)Canalicular ABC transportersBile acid efflux pumps
02

Mechanism of action

Drugs interact with these transporters by inducing their expression through the activation of nuclear receptors such as FXR, PXR, and PPAR-alpha, which upregulate the transcription of the transporter genes [10, 15, 19]. Additionally, some drugs act as competitive or non-competitive inhibitors that block the efflux of bile acids or bilirubin, leading to toxicity, while others serve as substrates that are actively cleared from the liver into the bile [6, 13, 23].

03

Biological functions

Bile acid transportBile formationDetoxificationDrug effluxLipid transportBilirubin excretion
04

Disease associations

CholestasisProgressive familial intrahepatic cholestasis (PFIC)Dubin-Johnson syndromeDrug-induced liver injury (DILI)Gallstones (Cholelithiasis)Intrahepatic cholestasis of pregnancy (ICP)Cancer (Multidrug resistance)
05

Safety considerations

Drug-induced liver injury (DILI)Drug-drug interactions (DDI)HepatotoxicityCholestatic jaundiceHyperbilirubinemia
06

Interacting drugs

Ursodeoxycholic acid

9 more in the full profile.

07

Biomarkers

Serum bile acidsConjugated bilirubinGamma-glutamyl transferase (GGT)Alkaline phosphatase (ALP)Alanine aminotransferase (ALT)

Beyond the preview

Go deeper on ATP-binding cassette subfamily C member 2 (ABCC2) and ATP-binding cassette subfamily B member 4 (ABCB4) (ABCC2/ABCB4/ABCB11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP-binding cassette subfamily C member 2 (ABCC2) and ATP-binding cassette subfamily B member 4 (ABCB4) (ABCC2/ABCB4/ABCB11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call